Primary care physicians aren’t quick to diagnose lymphedema in patients with obesity, a situation that needs to change, ...

Misinterpretation of MRI findings by clinicians focused on earlier intervention is leading to increased rates of ...

Heart disease is a leading global problem, and blocked arteries can reduce blood flow, increasing the risk of heart attacks ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

Learn the 7 critical warning signs of kidney failure and proven methods to protect and restore kidney function before ...

ST. ALBERT, AB / ACCESS Newswire / June 4, 2025 / Hello and welcome! I'm Dr. A. Fahoum, and I'm honoured to introduce myself and my clinic "Cardio Connect Healthcare Network", located in the heart of ...

Methods: We retrospectively reviewed cases performed over the last 20 years at our center as part of a Quality Improvement project, searching PACS for lymphoscintigraphy studies for evaluation of ...

The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to ...

The point-of-care ultrasound devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors ...